
David Patrick Angwin
Supervisory Patent Examiner (ID: 8828, Phone: (571)270-3735 , Office: P/3742 )
| Most Active Art Unit | 3729 |
| Art Unit(s) | 3754, 3729, 3742, 4155 |
| Total Applications | 557 |
| Issued Applications | 367 |
| Pending Applications | 22 |
| Abandoned Applications | 173 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18683954
[patent_doc_number] => 11779664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Targeted contrast agents for MRI of alpha-synuclein deposition
[patent_app_type] => utility
[patent_app_number] => 17/737928
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14475
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737928 | Targeted contrast agents for MRI of alpha-synuclein deposition | May 4, 2022 | Issued |
Array
(
[id] => 17981278
[patent_doc_number] => 20220347314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => MICROBUBBLE-CHEMOTHERAPEUTIC AGENT COMPLEX FOR SONODYNAMIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/734484
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734484 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | May 1, 2022 | Issued |
Array
(
[id] => 18418517
[patent_doc_number] => 20230172975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Gold-Platinum Based Bi-Metallic Nanocrystal Suspensions, Electrochemical Manufacturing Processes Therefor and Uses for the Same
[patent_app_type] => utility
[patent_app_number] => 17/708253
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17708253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/708253 | Gold-Platinum Based Bi-Metallic Nanocrystal Suspensions, Electrochemical Manufacturing Processes Therefor and Uses for the Same | Mar 29, 2022 | Abandoned |
Array
(
[id] => 18043484
[patent_doc_number] => 11517416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Bioartificial pancreas
[patent_app_type] => utility
[patent_app_number] => 17/697692
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 12320
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697692 | Bioartificial pancreas | Mar 16, 2022 | Issued |
Array
(
[id] => 17718945
[patent_doc_number] => 20220211664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => LYMPH DIRECTING PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 17/697694
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697694 | LYMPH DIRECTING PRODRUGS | Mar 16, 2022 | Abandoned |
Array
(
[id] => 17593628
[patent_doc_number] => 20220143201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMPOSITION COMPRISING A POLYMERIC REAGENT
[patent_app_type] => utility
[patent_app_number] => 17/586495
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586495 | COMPOSITION COMPRISING A POLYMERIC REAGENT | Jan 26, 2022 | Abandoned |
Array
(
[id] => 17718913
[patent_doc_number] => 20220211632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/580988
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580988 | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery | Jan 20, 2022 | Issued |
Array
(
[id] => 18970509
[patent_doc_number] => 20240050601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOSITIONS AND ASSOCIATED METHODS FOR SUSTAINED-RELEASE OF RADIOACTIVE AGENTS AND THEIR APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/259438
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259438
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259438 | COMPOSITIONS AND ASSOCIATED METHODS FOR SUSTAINED-RELEASE OF RADIOACTIVE AGENTS AND THEIR APPLICATIONS | Dec 27, 2021 | Pending |
Array
(
[id] => 17625889
[patent_doc_number] => 20220160904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES
[patent_app_type] => utility
[patent_app_number] => 17/643734
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17643734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/643734 | Chelating platform for delivery of radionuclides | Dec 9, 2021 | Issued |
Array
(
[id] => 19777462
[patent_doc_number] => 12226483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use
[patent_app_type] => utility
[patent_app_number] => 17/538770
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 18858
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538770 | Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use | Nov 29, 2021 | Issued |
Array
(
[id] => 17472432
[patent_doc_number] => 20220079936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => MULTI-ARM POLYMER PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 17/535385
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535385 | MULTI-ARM POLYMER PRODRUGS | Nov 23, 2021 | Abandoned |
Array
(
[id] => 17532272
[patent_doc_number] => 20220110881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/523442
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523442 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | Nov 9, 2021 | Abandoned |
Array
(
[id] => 17596944
[patent_doc_number] => 20220146518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => TAG FOR LABELING BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/523628
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523628 | TAG FOR LABELING BIOMOLECULES | Nov 9, 2021 | Abandoned |
Array
(
[id] => 17426694
[patent_doc_number] => 20220054402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITIONS AND METHODS FOR EXTRACTING, STABILIZING, AND MANUFACTURING STABLE DOSAGE FORMS OF PSILOCIN, PSYCHEDELIC DRUGS, ENTHEOGENS, AND MEDICINAL MUSHROOMS AS NANO-DIMENSIONAL DRUG DELIVERY STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 17/518091
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518091 | COMPOSITIONS AND METHODS FOR EXTRACTING, STABILIZING, AND MANUFACTURING STABLE DOSAGE FORMS OF PSILOCIN, PSYCHEDELIC DRUGS, ENTHEOGENS, AND MEDICINAL MUSHROOMS AS NANO-DIMENSIONAL DRUG DELIVERY STRUCTURES | Nov 2, 2021 | Pending |
Array
(
[id] => 18865714
[patent_doc_number] => 20230420151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => PHOSPHATE BASED TARGETS
[patent_app_type] => utility
[patent_app_number] => 18/033911
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033911
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033911 | PHOSPHATE BASED TARGETS | Oct 28, 2021 | Pending |
Array
(
[id] => 17412822
[patent_doc_number] => 20220047726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => FORMATION AND USES OF EUROPIUM
[patent_app_type] => utility
[patent_app_number] => 17/511769
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511769 | FORMATION AND USES OF EUROPIUM | Oct 26, 2021 | Abandoned |
Array
(
[id] => 17546757
[patent_doc_number] => 20220118098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => MULTI-CONJUGATES COMPRISING A MONO-SUBSTITUTED HOMO-BIVALENT LINKER
[patent_app_type] => utility
[patent_app_number] => 17/503053
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503053 | MULTI-CONJUGATES COMPRISING A MONO-SUBSTITUTED HOMO-BIVALENT LINKER | Oct 14, 2021 | Pending |
Array
(
[id] => 17472552
[patent_doc_number] => 20220080056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => DENDRIMER COMPOSITIONS AND USE IN TREATMENT OF NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/484175
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484175
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484175 | DENDRIMER COMPOSITIONS AND USE IN TREATMENT OF NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL DISORDERS | Sep 23, 2021 | Abandoned |
Array
(
[id] => 18938234
[patent_doc_number] => 20240033373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => TARGETED, INTRACELLULAR DELIVERY OF THERAPEUTIC PEPTIDES USING SUPRAMOLECULAR NANOMATERIALS
[patent_app_type] => utility
[patent_app_number] => 18/043286
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043286 | TARGETED, INTRACELLULAR DELIVERY OF THERAPEUTIC PEPTIDES USING SUPRAMOLECULAR NANOMATERIALS | Aug 30, 2021 | Pending |
Array
(
[id] => 17272587
[patent_doc_number] => 20210378785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHOD FOR MAKING HYDROGEL MARKERS
[patent_app_type] => utility
[patent_app_number] => 17/411117
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411117 | METHOD FOR MAKING HYDROGEL MARKERS | Aug 24, 2021 | Pending |